Search

Search Constraints

You searched for: Author/Creator Behm, Brian

Search Results

3. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. (February 2022)

4. Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study. (January 2022)

6. Inherent Immune Cell Variation Within Colonic Segments Presents Challenges for Clinical Trial Design. (2nd April 2020)